Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and four other institutions have developed a molecular test to identify the presence of brain ...

IDH mutation status impact on in vivo hypoxia biomarkers expression: New insights from a clinical, nuclear imaging, and immunohistochemical study in 34 patients with glioma. Background: Cerebrospinal ...

Add Yahoo as a preferred source to see more of our stories on Google. A new brain cancer test using spinal fluid detects tumors with 100% accuracy, offering safer diagnosis and fewer risky biopsies.

Analysis of the cerebrospinal fluid can detect whether a person has Alzheimer's disease before symptoms appear. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have ...

Blood-based biomarker test combining plasma phosphorylated tau 217 (p-tau217) and amyloid beta 1-42 (Aβ1-42) can accurately ...

A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers ...

Developing rapid clinical testing for cerebrospinal fluid (CSF) leaks after trauma, surgery, tumors, and other defects are vital, because such leaks can cause life-threatening conditions, such as ...

Researchers developed a single-use sensor strip that can be used with a circuit board to detect cerebrospinal fluid leaks. They collected nine clinical samples and introduced the test fluid into a ...

For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI scans may reveal a suspicious-looking lesion, but the only sure way to ...